Cancer Clinical Trial
Official title:
Adaptated Physical Activity During Chemotherapy: Evaluation of the Psychological, Physiological and Biological Impact
Although treatments significantly increase the life expectancy of cancer patients, their
quality of life is more or less reduced. The development of supportive care, such as
physical activity, is one of the tools that should be promoted to maintain quality of life
and reduce treatment side effects, including fatigue.
This study was developed to understand the different biopsychosocial effects of a physical
activity program carried out with patients suffering from various types of cancers, and to
facilitate and improve the implementation of this type of activity in health care
facilities.
Study randomized, controlled, cross-over intervention evaluating a 12-week supervised and
adapted physical activity program.
Participants were assigned to one of two groups: Group A which first follows a 12-week
physical activity program, then undergoes usual care for 12 additional weeks, or Group B,
which continues usual care for 12 weeks (control group) and then starts the physical
activity program for 12 additional weeks. Quality of life (with questionnaires for 2 groups)
, well-being, fatigue, physical capacity, leptin concentration, goal setting and level of
physical activity are evaluated during this protocol.
By understanding the multidimensional effects of a physical activity program for various
cancer types, depending on the time of proposing the program, by evaluating the correlations
among all these variables, and by evaluating long-term effects, the IPCAPA study contributes
to identifying the physical activity program which will be effective, viable and feasible
for all patients undergoing chemotherapy, whatever the type of cancer.
Cancer is one of the leading causes of deaths in the world, with an estimated incidence of
14.1 million per year (2012) in the world, and 355,000 in France. Despite an increase in
survival rates after cancer treatment, the psychological impact of the diagnosis and the
aggressiveness of treatments such as chemotherapy tend to significantly decrease the quality
of life of patients during and after cancer care.
Helping patients to support regular treatment is a crucial point in increasing compliance
with treatment and thus increasing the cure rate, and many supportive care have been
developed and implemented. Physical activity, now regarded as a non-drug therapy, provides
many benefits, both in tertiary and secondary prevention during cancer treatment. Many
studies have shown a decrease in mortality with physical activity during and after
treatment, especially for breast, colon and prostate cancer. Regular physical activity
during treatment increases patients' quality of life, for many types of cancer. The
prevalence of fatigue during cancer is well described, as well as the need to effectively
treat cancer related fatigue in order to enable patients to better withstand their
treatment. Within the last decade, it has been pointed out that physical activity is one of
the most efficient ways to combat cancer related fatigue.
From a psychological point of view, physical activity can decrease anxiety, depression and
stress, and can also increase self-esteem, perceived control, and overall mental health.
Exercise physiologically increases physical capacity, strength, endurance and flexibility,
and decreases physical symptoms such as pain and nausea. Biologically, physical activity
often results in beneficial changes in the circulation level of adiponectin, leptin,
insulin, and C-reactive protein, especially during breast, prostate and gastric cancer.
Overall, physical activity during cancer treatment results in improvement in general quality
of life, including mental, physical and social dimensions.
Although physical activity during cancer treatment is known to induce many benefits,
depending on the cancer and the type of treatment, it is difficult to clearly investigate
the effects of physical activity during cancer and how they interact or are sequential.
A better understanding of the close relationship between the psychological and physiological
aspects might allow us to better understand the effects of physical activity during cancer.
Exercise programs used during cancer treatment vary from one study to another in their
duration, intensity and frequency. Furthermore, not all patients are included and not all
types of cancers and treatment are considered.
Our study, named Institut Paoli Calmettes Adapted Physical Activity, was developed to
understand the different biopsychosocial effects of a physical activity program carried out
with patients suffering from various type of cancers, and to facilitate and improve the
implementation of this type of activity in health care facilities.
;
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|